A detailed history of Somerset Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Somerset Group LLC holds 6,803 shares of ABBV stock, worth $1.38 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares
6,803
Previous 6,803 -0.0%
Holding current value
$1.38 Million
Previous $1.24 Million 5.82%
% of portfolio
1.06%
Previous 1.18%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $95,892 - $109,260
-600 Reduced 8.1%
6,803 $1.24 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $102,997 - $119,235
-771 Reduced 9.43%
7,403 $1.1 Million
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $4,637 - $5,771
-35 Reduced 0.43%
8,174 $1.1 Million
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $2,892 - $3,330
20 Added 0.24%
8,209 $1.31 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $96,817 - $116,109
-700 Reduced 7.87%
8,189 $1.32 Million
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $3,027 - $3,849
-22 Reduced 0.25%
8,889 $1.36 Million
Q3 2021

Nov 10, 2021

SELL
$106.4 - $120.78 $42,560 - $48,312
-400 Reduced 4.3%
8,911 $961,000
Q2 2021

Aug 10, 2021

BUY
$105.21 - $117.21 $6,102 - $6,798
58 Added 0.63%
9,311 $1.05 Million
Q1 2021

May 10, 2021

SELL
$102.3 - $112.62 $20,460 - $22,524
-200 Reduced 2.12%
9,253 $1 Million
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $4,185 - $5,650
52 Added 0.55%
9,453 $1.01 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $807,639 - $947,902
9,401 New
9,401 $823,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Somerset Group LLC Portfolio

Follow Somerset Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Somerset Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Somerset Group LLC with notifications on news.